Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
2.34 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 1.34 | 2.703 | 2.703 | 2.71 | 2.703 | 2.449 | 2.456 | 0.641 | 0 | 0 | 0 | 0.184 | 0.197 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 0.09 | 0.09 | 0.086 | 0.187 | 0.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 1.34 | 2.703 | 2.703 | 2.62 | 2.613 | 2.363 | 2.269 | 0.151 | 0 | 0 | 0 | 0.184 | 0.197 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 1 | 1 | 1 | 0.967 | 0.967 | 1.035 | 0.924 | 0.236 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 8.971 | 27.639 | 20.989 | 10.235 | 13.522 | 11.979 | 10.281 | 7.709 | 4.781 | 3.277 | 2.272 | 1.681 | 1.159 | 1.464 | 1.522 | 1.176 | 2.214 | 0.198 | 0 | 0 | 0.01 |
| Algemene en administratieve kosten
| 8.425 | 13.811 | 5.937 | 4.232 | 3.722 | 4.083 | 2.759 | 2.452 | 2.602 | 2.629 | 2.032 | 1.203 | 1.276 | 1.509 | 1.262 | 1.504 | 0.918 | 0.215 | 0.045 | 0.28 | 0.05 |
| Verkoop- en marketingkosten
| -0.287 | 1.851 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 8.138 | 15.662 | 5.937 | 4.232 | 3.722 | 4.083 | 2.759 | 2.452 | 2.602 | 2.629 | 2.032 | 1.203 | 1.276 | 1.509 | 1.262 | 1.504 | 0.918 | 0.215 | 0.045 | 0.28 | 0.05 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.44 | -0.01 |
| Bedrijfskosten
| 17.109 | 43.301 | 26.926 | 14.467 | 17.244 | 16.062 | 13.04 | 10.161 | 7.383 | 5.906 | 4.304 | 2.884 | 2.435 | 2.973 | 2.784 | 2.68 | 3.132 | 0.413 | 0.045 | 0.72 | 0.05 |
| Bedrijfsresultaat
| -15.769 | -40.598 | -24.223 | -11.757 | -14.631 | -13.527 | -10.771 | -10.01 | -7.383 | -5.906 | -4.304 | 2.884 | -2.435 | -2.973 | -2.784 | -2.68 | -3.132 | -0.413 | -0.045 | -0.72 | -0.05 |
| Bedrijfsresultaat ratio
| -11.768 | -15.02 | -8.962 | -4.338 | -5.413 | -5.523 | -4.386 | -15.616 | 0 | 0 | 0 | 15.652 | -12.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 20.857 | 2.934 | 0.893 | -0.438 | -0.45 | -0.03 | -0.01 | -0.017 | -0.003 | 0.214 | -0.165 | -0.184 | 0.836 | 0.01 | 0.021 | 5.287 | -0.104 | -0.002 | -0.001 | 0 | 0 |
| Inkomen voor belasting
| 5.088 | -37.664 | -22.989 | -11.511 | -14.055 | -12.727 | -10.08 | -9.629 | -7.233 | -5.692 | -4.437 | -3.254 | -1.585 | -2.962 | -2.763 | 2.607 | -3.236 | -0.415 | -0.046 | -0.72 | -0.05 |
| Inkomen voor belasting ratio
| 3.797 | -13.934 | -8.505 | -4.248 | -5.2 | -5.197 | -4.104 | -15.022 | 0 | 0 | 0 | -17.662 | -8.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0.1 | -2.878 | 0.192 | 0.3 | -0.8 | 0.4 | 1.335 | -0.001 | 0.004 | -0.205 | 0.09 | -0.024 | 0.015 | -0.003 | 0.162 | 3.236 | 0.415 | 0.046 | 0 | 0 |
| Nettowinst
| 5.525 | -37.764 | -22.238 | -11.511 | -14.355 | -12.727 | -10.48 | -10.964 | -7.232 | -5.696 | -4.232 | -3.344 | -1.561 | -2.977 | -2.76 | -2.769 | -3.236 | -0.415 | -0.046 | -0.72 | -0.05 |
| Nettowinstmarge
| 4.123 | -13.971 | -8.227 | -4.248 | -5.311 | -5.197 | -4.267 | -17.105 | 0 | 0 | 0 | -18.151 | -7.909 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.017 |
| Verwaterde WPA
| 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.017 |
| EBITDA
| -15.573 | -36.976 | -25.039 | -11.312 | -14.173 | -13.491 | -10.756 | -9.989 | -7.376 | -5.675 | -4.134 | -2.856 | -2.374 | -2.916 | -2.715 | -2.665 | -3.024 | -0.413 | -0.045 | -0.72 | -0.05 |
| EBITDA ratio
| -11.622 | -13.68 | -9.263 | -4.174 | -5.243 | -5.509 | -4.379 | -15.583 | 0 | 0 | 0 | -15.501 | -12.024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |